informed the exchanges today that it has received the Establishment Inspection Report (EIR) with Voluntary Action Initiated (VAl) status from USFDA for Unit IV, a general injectable formulation manufacturing facility of the Company.
The stock has surged more than 15% in trade today on this news development.
Aurobindo Pharma Ltd is currently trading at Rs575.55 up by Rs75.35 or 15.06% from its previous closing of Rs500.20 on the BSE.
The scrip opened at Rs550.20 and has touched a high and low of Rs594 and Rs550.20 respectively. So far 1,01,55,127 (NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs29,308.65cr.